Withdrawal-Emergent Dyskinesias following Varenicline Therapy

Varenicline (Chantix[R]) is a nicotinic acetylcholine receptor partial agonist used to aid smoking cessation. Adverse psychiatric and behavioral effects of the drug are recognized and national drug monitoring has included reports of tardive dyskinesia, but no cases have been described in the literat...

Descripción completa

Detalles Bibliográficos
Autores principales: Toffey, Brittany A, Rabin, Marcie, Kurlan, Roger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Open 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475689/
https://www.ncbi.nlm.nih.gov/pubmed/26106454
http://dx.doi.org/10.2174/1874205X01509010007
Descripción
Sumario:Varenicline (Chantix[R]) is a nicotinic acetylcholine receptor partial agonist used to aid smoking cessation. Adverse psychiatric and behavioral effects of the drug are recognized and national drug monitoring has included reports of tardive dyskinesia, but no cases have been described in the literature. We now report the first two cases of varenicline-related withdrawal emergent dyskinesias.

Ejemplares similares